Natural Capital and Shrug Capital led a $187m Series C round in Varda.

Natural Capital and Shrug Capital, a venture capital firms, led a $187m Series C round in Varda, a microgravity-enabled life sciences company, with participation from Founders Fund, Peter Thiel, Khosla Ventures, Caffeinated Capital, Lux Capital, and Also Capital. "With this capital, Varda will continue to increase our flight cadence and build out the pharmaceutical lab that will deliver the world's first microgravity-enabled drug formulation," Will Bruey, Varda CEO.